Advertisement

Topics

Cellix Biosciences Announces Regulatory Pathway Confirmation for CLX-106 in the U.S.

14:09 EDT 11 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Cellix Biosciences Inc. (“Cellix Bio”), a development-stage pharmaceutical company, today announced confirmation from the U.S. Food and Drug Administration (FDA) that the 505(b)(2) regulatory pathway is appropriate for devel...

Other Sources for this Article

Cellix Biosciences Inc
Subbu Apparsundaram, +1 862-485-7489
subbu@cellixbio.com

NEXT ARTICLE

More From BioPortfolio on "Cellix Biosciences Announces Regulatory Pathway Confirmation for CLX-106 in the U.S."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...